Levofloxacina Bioindustria L.I.M.

Levofloxacin, the active ingredient in Levofloxacina Bioindustria L.I.M., is a fluoroquinolone antibiotic presented as an intravenous formulation for systemic use. It treats a range of serious bacterial infections in adult patients, especially when rapid plasma concentrations are required.

GNH USA supplies Levofloxacina Bioindustria L.I.M. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Levofloxacin is indicated for several serious bacterial infections that often require intravenous therapy.

- Community‑Acquired Bacterial Pneumonia: achieves clinical cure and bacterial eradication. - Complicated Urinary Tract Infection: resolves infection and prevents recurrence. - Intra‑Abdominal Infections: provides effective coverage against mixed aerobic and anaerobic pathogens. - Skin and Soft‑Tissue Infections: treats moderate to severe infections caused by susceptible organisms. - Acute Bacterial Sinusitis: reduces symptoms and eliminates causative bacteria.

Levofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery or loose. - Headache: transient and often resolves without treatment. - Dizziness: occasional light‑headed sensation. - Rash: mild skin erythema or pruritus. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur without warning. - QT interval prolongation: can precipitate cardiac arrhythmias. - Clostridioides difficile infection: severe colitis requiring medical attention. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Peripheral neuropathy: persistent numbness or tingling. - Hepatotoxicity: rare cases of liver injury.

Levofloxacin requires careful consideration of patient‑specific factors before use.

- Renal impairment: dose adjustment may be needed based on creatinine clearance. - History of tendon disorders: avoid use in patients with prior tendon injury. - Cardiac risk: monitor QT interval in patients with known prolongation or electrolyte disturbances. - Hypersensitivity: discontinue if allergic reaction occurs. - Pregnancy and lactation: safety not established; use only if benefits outweigh risks. - Pediatric use: contraindicated in children due to risk of musculoskeletal toxicity. - Store at ambient temperature: keep in original container, protect from moisture and light.

Levofloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids or supplements containing magnesium/aluminum: reduce levofloxacin absorption. - Warfarin: may increase INR and bleeding risk. - Cyclosporine: can raise cyclosporine plasma levels. - Theophylline: may increase theophylline toxicity. - Quinidine: heightened risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - NSAIDs: combined use may lower seizure threshold. - Corticosteroids: increased risk of tendon rupture. - Diabetic agents: potential for hypoglycemia. - SSRIs or other QT‑prolonging drugs: monitor cardiac rhythm. - Rifampin: may reduce levofloxacin concentrations.